DSM, already one of the biggest names in the human nutrition business, became the biggest supplier of omega-3s when it acquired fish-oil leader Ocean Nutrition Canada. Here's an insider's look into DSM's strategy.
FDA has agreed to issue a new, revised New Dietary Ingredients draft guidance after a top-level meeting including Sens. Tom Harkin and Orrin Hatch and Commissioner Margaret Hamburg. No timeline for the new process was immediately available.
Royal DSM plans to buy leading fish oil supplier Ocean Nutrition Canada for $532 million. The omega-3 powerhouse is set to take on pharma, but will the deal create competition between its fish and algae omega-3 products?
With FDA prompting a DMAA exodus from the market, one pre-workout product that features dendrobium extract is benefitting. But while dendrobium might have some advantages over DMAA, experts suspect that some extracts might be spiked.
Algae has great promise as a sustainable source of omega-3s, but up to now it hasn't been possible to certify most algal sources as organic. While that might be about to change, will ingredient suppliers get on board?
A meta-analysis released Monday by the Journal of the American Medical Association concluded that omega-3s intake didn't help patients who already have cardiovascular disease. But industry sources took issue with the study's structure and disagreed with its conclusions.
A report from a fisheries task force recommends cutting the worldwide forage fish harvest in half. Sources familiar with the species mentioned in the report that supply omega-3s—anchovies, menhaden and krill—dispute the report's conclusions and say there is enough information to operate these fisheries sustainably.
The practice of dry labbing, or approving test samples without actually doing any tests, has occurred in the supplements industry for years. Now a national TV show on the subject may provide the "seed event" to spur action on the problem.